Anti-DLL4 Antibody (Demcizumab)
Catalog No.
F1542
Anti-DLL4 Antibody (Demcizumab)
Featured Products
Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody. Demcizumab is a potent Notch pathway inhibitor. Demcizumab is effective alone or in combination with chemotherapeutic agents in a variety of cancer models.
145 kDa
Dry ice
1243262-17-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
OMP-21M18
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NR61
Human
Unconjugated
Monoclonal
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
DLL4
Please avoid freeze-thaw cycles.